Physician profile
Cody Aull
NPI 1619150349
$1,875.39
in general payments reported to CMS, 2019-2025
15 companies · $540 in 2025
The $540 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.96 · 2020: $40.26 · 2021: $17.04 · 2022: $71.72 · 2023: $287 · 2024: $860 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207 · Travel and Lodging: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,207.10 |
| Travel and Lodging | $479.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $894.17 | 2024-2025 | Propel, Quadcut |
| Optinose US, INC. | $266.81 | 2021-2024 | |
| Stryker Corporation | $190.57 | 2025 | Scopis Ent, Hemopore |
| Astrazeneca Pharmaceuticals LP | $86.41 | 2025 | Tezspire, Fasenra |
| Regeneron Healthcare Solutions, INC. | $76.08 | 2022-2023 | Dupixent |
| Glaxosmithkline, LLC. | $73.76 | 2024-2025 | Nucala |
| Genzyme Corporation | $57.14 | 2022-2025 | |
| Aerin Medical INC. | $56.94 | 2024-2025 | |
| Olympus America INC. | $32.93 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $29.60 | 2025 | |
| Cochlear Americas | $28.03 | 2019 | |
| Vertical Pharmaceuticals, LLC | $24.97 | 2023 | Dsuvia |
| Medtronic USA, INC. | $20.45 | 2019 | |
| Intersect Ent, INC. | $18.81 | 2020 | |
| Phadia US INC. | $18.72 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Aull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.